https://www.selleckchem.com/products/a-366.html
These findings indicated a possible mechanism via the CD13/NAB1/MAPK pathway of which activity was restrained. Ubenimex exert the inhibitory effect on GC metastasis by targeting CD13, in which NAB1 expression and the activation of MAPK signaling pathway were both suppressed. This study identified a promising target for the inhibition of GC metastasis. Ubenimex exert the inhibitory effect on GC metastasis by targeting CD13, in which NAB1 expression and the activation of MAPK signaling pathway were both suppressed. This study identified a p
Like
Comment
Share
